Literature DB >> 32209364

Understanding the distinct subcellular trafficking of CD36 and GLUT4 during the development of myocardial insulin resistance.

Joost J F P Luiken1, Miranda Nabben2, Dietbert Neumann3, Jan F C Glatz2.   

Abstract

CD36 and GLUT4 are the main cardiac trans-sarcolemmal transporters for long-chain fatty acids and glucose, respectively. Together they secure the majority of cardiac energy demands. Moreover, these transporters each represent key governing kinetic steps in cardiac fatty acid and glucose fluxes, thereby offering major sites of regulation. The underlying mechanism of this regulation involves a perpetual vesicle-mediated trafficking (recycling) of both transporters between intracellular stores (endosomes) and the cell surface. In the healthy heart, CD36 and GLUT4 translocation to the cell surface is under short-term control of the same physiological stimuli, most notably increased contraction and insulin secretion. However, under chronic lipid overload, a condition that accompanies a Western lifestyle, CD36 and GLUT4 recycling are affected distinctly, with CD36 being expelled to the sarcolemma while GLUT4 is imprisoned within the endosomes. Moreover, the increased CD36 translocation towards the cell surface is a key early step, setting the heart on a route towards insulin resistance and subsequent contractile dysfunction. Therefore, the proteins making up the trafficking machinery of CD36 need to be identified with special focus to the differences with the protein composition of the GLUT4 trafficking machinery. These proteins that are uniquely dedicated to either CD36 or GLUT4 traffic may offer targets to rectify aberrant substrate uptake seen in the lipid-overloaded heart. Specifically, CD36-dedicated trafficking regulators should be inhibited, whereas such GLUT4-dedicated proteins would need to be activated. Recent advances in the identification of CD36-dedicated trafficking proteins have disclosed the involvement of vacuolar-type H+-ATPase and of specific vesicle-associated membrane proteins (VAMPs). In this review, we summarize these recent findings and sketch a roadmap of CD36 and GLUT4 trafficking compatible with experimental findings.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD36; Cardiomyocytes; Endosomes; GLUT4; Lipid-induced insulin resistance; Translocation; Vacuolar-type H(+)-ATPase; Vesicle-associated membrane proteins

Mesh:

Substances:

Year:  2020        PMID: 32209364     DOI: 10.1016/j.bbadis.2020.165775

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  13 in total

1.  Renal denervation ameliorates cardiac metabolic remodeling in diabetic cardiomyopathy rats by suppressing renal SGLT2 expression.

Authors:  Jun-Yu Huo; Wan-Ying Jiang; Shi-Geng Zhang; Yi-Ting Lyu; Jie Geng; Meng Chen; Yuan-Yuan Chen; Zhi-Xin Jiang; Qi-Jun Shan
Journal:  Lab Invest       Date:  2021-11-13       Impact factor: 5.662

Review 2.  Endosomal trafficking in metabolic homeostasis and diseases.

Authors:  Jerome Gilleron; Anja Zeigerer
Journal:  Nat Rev Endocrinol       Date:  2022-10-10       Impact factor: 47.564

3.  Deletion of LDLRAP1 Induces Atherosclerotic Plaque Formation, Insulin Resistance, and Dysregulated Insulin Response in Adipose Tissue.

Authors:  Tani Leigh; Tatsuo Kawai; Kyle Preston; Sheri Kelemen; Rachael Okune; Amanda St Paul; Cali Corbett; Amanda M Peluzzo; Jun Yu; Rosario G Scalia; Michael V Autieri
Journal:  Am J Pathol       Date:  2022-04-20       Impact factor: 5.770

Review 4.  Insulin signaling in the heart.

Authors:  E Dale Abel
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-31       Impact factor: 5.900

Review 5.  Putative Role of Protein Palmitoylation in Cardiac Lipid-Induced Insulin Resistance.

Authors:  Francesco Schianchi; Jan F C Glatz; Artur Navarro Gascon; Miranda Nabben; Dietbert Neumann; Joost J F P Luiken
Journal:  Int J Mol Sci       Date:  2020-12-11       Impact factor: 5.923

Review 6.  The role of CD36 in cardiovascular disease.

Authors:  Hongyang Shu; Yizhong Peng; Weijian Hang; Jiali Nie; Ning Zhou; Dao Wen Wang
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

Review 7.  Effects of Lipid Overload on Heart in Metabolic Diseases.

Authors:  An Yan; Guinan Xie; Xinya Ding; Yi Wang; Liping Guo
Journal:  Horm Metab Res       Date:  2021-12-10       Impact factor: 2.936

8.  Run for your life: can exercise be used to effectively target GLUT4 in diabetic cardiac disease?

Authors:  Peter R T Bowman; Godfrey L Smith; Gwyn W Gould
Journal:  PeerJ       Date:  2021-05-25       Impact factor: 2.984

Review 9.  The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications-Update in Pathogenesis, Treatment and Monitoring.

Authors:  Kamila Puchałowicz; Monika Ewa Rać
Journal:  Cells       Date:  2020-08-11       Impact factor: 6.600

Review 10.  CD36 Signaling in Diabetic Cardiomyopathy.

Authors:  Xudong Zhang; Jiahui Fan; Huaping Li; Chen Chen; Yan Wang
Journal:  Aging Dis       Date:  2021-06-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.